These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36187120)

  • 1. Case report: A particularly rare case of endogenous hyperinsulinemic hypoglycemia complicated with pregnancy treated with short-acting somatostatin analog injections.
    Barsi Á; Beke A; Sármán B
    Front Endocrinol (Lausanne); 2022; 13():964481. PubMed ID: 36187120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report.
    Skajaa GO; Mathiesen ER; Iyore E; Beck-Nielsen H; Jimenez-Solem E; Damm P
    BMC Res Notes; 2014 Nov; 7():804. PubMed ID: 25404386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Neurodevelopmental Outcome in a Small-for-Gestational-Age Infant With Symptomatic Hyperinsulinemic Hypoglycemia, Gaze Preference, and Infantile Spasms.
    Chandran S; Teoh KW; Janardhan K; Yap F
    Front Endocrinol (Lausanne); 2022; 13():818252. PubMed ID: 35721755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn.
    Koklu E; Ozkan KU; Sayar H; Koklu S; Keskin M
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1153-6. PubMed ID: 23751383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of octreotide for the treatment of congenital hyperinsulinism: a prospective, open-label clinical trial and an observational study in Japan using a nationwide registry.
    Hosokawa Y; Kawakita R; Yokoya S; Ogata T; Ozono K; Arisaka O; Hasegawa Y; Kusuda S; Masue M; Nishibori H; Sairenchi T; Yorifuji T
    Endocr J; 2017 Sep; 64(9):867-880. PubMed ID: 28701683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
    Durmaz E; Flanagan SE; Parlak M; Ellard S; Akcurin S; Bircan I
    J Clin Res Pediatr Endocrinol; 2014; 6(2):119-21. PubMed ID: 24932607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.
    Kane C; Lindley KJ; Johnson PR; James RF; Milla PJ; Aynsley-Green A; Dunne MJ
    J Clin Invest; 1997 Oct; 100(7):1888-93. PubMed ID: 9312191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide-induced hepatitis in a child with persistent hyperinsulinemia hypoglycemia of infancy.
    Ben-Ari J; Greenberg M; Nemet D; Edelstein E; Eliakim A
    J Pediatr Endocrinol Metab; 2013; 26(1-2):179-82. PubMed ID: 23327813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge.
    Dardano A; Daniele G; Lupi R; Napoli N; Campani D; Boggi U; Del Prato S; Miccoli R
    Front Endocrinol (Lausanne); 2020; 11():10. PubMed ID: 32047477
    [No Abstract]   [Full Text] [Related]  

  • 10. Seizure due to somatostatin analog discontinuation in a case diagnosed as congenital hyperinsulinism novel mutation.
    Baş VN; Ozkan M; Zenciroğlu A; Cavuşoğlu YH; Cetinkaya S; Aycan Z
    J Pediatr Endocrinol Metab; 2012; 25(5-6):553-5. PubMed ID: 22876555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017-2018): Congenital hyperinsulinism, insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata's disease).
    Yamada Y; Kitayama K; Oyachi M; Higuchi S; Kawakita R; Kanamori Y; Yorifuji T
    J Diabetes Investig; 2020 May; 11(3):554-563. PubMed ID: 31742894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Long-Acting Somatostatin Analogue (Lanreotide) in an Adolescent with Diazoxide-Responsive Congenital Hyperinsulinism and Its Psychological Impact.
    Shah P; Rahman SA; McElroy S; Gilbert C; Morgan K; Hinchey L; Senniappan S; Levy H; Amin R; Hussain K
    Horm Res Paediatr; 2015; 84(5):355-60. PubMed ID: 26375451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: A novel
    Chandran S; Verma D; Rajadurai VS; Yap F
    Front Endocrinol (Lausanne); 2024; 15():1471596. PubMed ID: 39421536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine-Induced Hypoglycaemia in a Patient with Congenital Hyperinsulinism on Lanreotide Therapy.
    Giri D; Price V; Yung Z; Didi M; Senniappan S
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):347-50. PubMed ID: 27087264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation.
    Vieira TC; Bergamin CS; Gurgel LC; Moisés RS
    Pediatr Diabetes; 2010 Nov; 11(7):505-8. PubMed ID: 20042013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia.
    Dauriz M; Maneschi C; Castelli C; Tomezzoli A; Fuini A; Landoni L; Malleo G; Ferdeghini M; Bonora E; Moghetti P
    J Clin Endocrinol Metab; 2019 Mar; 104(3):773-778. PubMed ID: 30597028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel).
    Modan-Moses D; Koren I; Mazor-Aronovitch K; Pinhas-Hamiel O; Landau H
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2312-7. PubMed ID: 21697252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of hyperinsulinemia of undetermined origin, successfully treated with long-acting octreotide.
    Kondo T; Tomita S; Adachi H; Motoshima H; Taketa K; Matsuyoshi A; Tokunaga H; Miyamura N; Araki E
    Endocr J; 2005 Oct; 52(5):511-7. PubMed ID: 16284426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide therapy and restricted fetal growth: pregnancy in familial hyperinsulinemic hypoglycemia.
    Geilswijk M; Andersen LL; Frost M; Brusgaard K; Beck-Nielsen H; Frederiksen AL; Jensen DM
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28458896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism.
    Ros-Pérez P; Golmayo L; Cilleruelo ML; Gutiérrez C; Celaya P; Lacámara N; Martínez-Badás I; Güemes M; Argente J
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):947-950. PubMed ID: 32634108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.